Infinity Pharmaceuticals, Inc. Highlights Clinical Advances in Its Portfolio of Anti-Chaperone Agents and Announces Second Quarter Financial Results

CAMBRIDGE, Mass., Aug. 4, 2008 (PRIME NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today provided a research and development (R&D) update and announced financial results for the second quarter of 2008.